Antengene Corporation Limited, a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, announced...
Mind Medicine Inc., a leading biotech company developing psychedelic-inspired therapies, announced the initiation of Phase 2a proof-of-concept (POC) trial of lysergic acid diethylamide (LSD)...
BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today...
Evofem Biosciences, Inc. and Orion Biotechnology Canada Ltd. announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of...
Menarini Silicon Biosystems (MSB), a pioneer of single cell technologies, announced its new FFPE Rescue Application, to enable molecular testing on formalin-fixed, paraffin-embedded (FFPE)...
